1 |
Ahmad M, Al Gamal E, Othman A, et al (2011). Knowledge, attitudes and practices towards cancer prevention and care in Jordan. Report. Amman, Jordan: King Hussein Institute for Biotechnology and Cancer (KHIBC).
|
2 |
Ahmad MM (2014). Jordanians knowledge and beliefs about cancer. Global J Advances Pure Applied Sci, 4.
|
3 |
Ajape AA, Babata A, Abiola OO (2010). Knowledge of prostate cancer screening among native African urban population in Nigeria. Public Health, 1, 2.
|
4 |
Alhelih EM, Rabah DM, Arafa MA (2010). Analysis of perceived benefits and risks for prostate cancer screening in Saudi Arabia. J Medicine Medical Sci, 1, 302-8.
|
5 |
Anderson MM (2013). Testing the health belief model using prostate cancer screening intention: comparing four statistical approaches applied to data from the 2008-09 Nashville Men's Preventive Health Survey.
|
6 |
Arafa MA, Rabah DM, Wahdan IH (2012). Awareness of general public towards cancer prostate and screening practice in arabic communities: a comparative multi-center study. Asian Pac J Cancer Prev, 13, 4321-6.
DOI
ScienceOn
|
7 |
Atulomah NO, Olanrewaju MF, Amosu AM, et al (2010). Level of awareness, perception and screening behavior regarding prostate cancer among men in a rural community of ikenne local government area, Nigeria. Primary Prevention Insights.
|
8 |
Avery KN, Metcalfe C, Vedhara K, et al (2012). Predictors of attendance for prostate-specific antigen screening tests and prostate biopsy. European Urol, 62, 649-55.
DOI
|
9 |
Bloom JR, Stewart SL, Oakley-Girvans I, et al (2006). Family history, perceived risk, and prostate cancer screening among African American men. Cancer Epidemiol Biomarkers Prev, 15, 2167-73.
DOI
|
10 |
Brislin RW (1986). The wording and translation of research instruments. J Cross Cultural Psychol, 16, 340-59.
|
11 |
Carpenter CJ (2010). A meta-analysis of the effectiveness of health belief model variables in predicting behavior. Health Communicat, 25, 661-9.
DOI
|
12 |
Champion VL (1993). Instrument refinement for breast cancer screening behaviors. Nurs Res, 42, 139-43.
|
13 |
Drazer MW, Huo D, Schonberg MA, et al (2011). Populationbased patterns and predictors of prostate-specific antigen screening among older men in the United States. J Clin Oncol, 29, 1736-43.
DOI
|
14 |
Ferlay J, Soerjomataram I, Ervik M (2012). GLOBOCAN 2012 v1. 0, Cancer Incidence and Mortality Worldwide: IARC Cancer Base No. 10 [Internet], Int Agency Res Cancer, 2013.
|
15 |
IBM Corporation (2012). IBM SPSS Statistics for Windows, Version 21.0. NY: IBM Corp.
|
16 |
Ilic D, O'Connor D, Green S, et al (2011). Screening for prostate cancer: an updated Cochrane systematic review. BJU Int, 107, 882-91.
DOI
|
17 |
Odedina FT, Dagne G, LaRose-Pierre M, et al (2011a). Withingroup differences between native-born and foreign-born Black men on prostate cancer risk reduction and early detection practices. J Imm Minority Health, 13, 996-1004.
DOI
|
18 |
Kleier J (2010). Fear of and susceptibility to prostate cancer as predictors of prostate cancer screening among Haitian-American men. Urologic Nursing, 30, 179.
|
19 |
Loeb S, Vonesh EF, Metter EJ, et al (2011). What is the true number needed to screen and treat to save a life with prostatespecific antigen testing? J Clin Oncol, 29, 464-7.
DOI
|
20 |
Nakandi H, Kirabo M, Semugabo C, et al (2013). Knowledge, attitudes and practices of Ugandan men regarding prostate cancer. African J Urol, 19, 165-70.
DOI
|
21 |
Odedina FT, Dagne G, Pressey S, et al (2011b). Prostate cancer health and cultural beliefs of black men: The Florida Prostate Cancer Disparity Project. Infectious Agents Cancer, 6, 10-7.
DOI
ScienceOn
|
22 |
Odedina FT, Scrivens J, John J, et al (2011c). Modifiable Prostate Cancer Risk Reduction and Early Detection Behaviors in Black Men. Am J Health Behavior, 35, 470-84.
|
23 |
Oliver JS, Grindel CG, DeCoster J, et al (2011). Benefits, barriers, sources of influence, and prostate cancer screening among rural men. Pub Health Nursing, 28, 515-22.
DOI
|
24 |
Schroder FH (2012). Landmarks in prostate cancer screening. BJU Int, 110, 3-7.
DOI
|
25 |
Schroder FH, Hugosson J, Roobol MJ, et al (2012). Prostatecancer mortality at 11 years of follow-up. New England J Med, 366, 981-90.
DOI
|
26 |
Seo HS, Lee NK (2010). Predictors of PSA screening among men over 40 years of age who had ever heard about PSA. Korean J Urol, 51, 391-7.
DOI
|
27 |
Weinrich SP, Seger R, Miller BL, et al (2004). Knowledge of the limitations associated with prostate cancer screening among low-income men. Cancer Nursing, 27, 442-51.
|
28 |
Sharma M, Romas JA (2011). Theoretical foundations of health education and health promotion, Jones & Bartlett Publishers.
|
29 |
Siegel R, Naishadham D, Jemal A (2013). Cancer statistics, 2013. CA: Cancer J Clin, 63, 11-30.
DOI
|
30 |
Stewart B, Wild C (2014). World cancer report 2014, IARC Press, Int Agency Res Cancer [Epub ahead of print].
|